Kogenate

Kogenate Uses, Dosage, Side Effects, Food Interaction and all others data.

Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells

Antihemophilic Factor binds factor IXa along with calcium and phospholipid, This complex converts factor X to factor Xa to facilitate clotting cascade.

Trade Name Kogenate
Generic Antihemophilic factor, human recombinant
Antihemophilic factor, human recombinant Other Names Antihemophilic factor (recombinant), Antihemophilic factor recombinant, Antihemophilic factor, human recombinant, Antihemophilic factor, recombinant, Coagulation factor VIII, recombinant, Factor VIII (rDNA), Factor VIII (Recombinant), Factor VIII recombin, Factor VIII, recombinant, Human Factor VIII (Recombinant), Human factor VIII recombinant, Octocog alfa, rAHF, Recombinant antihemophilic factor VIII
Type
Formula C11794H18314N3220O3553S83
Weight 264725.5 Da
Groups Approved, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Kogenate
Kogenate

Uses

Kogenate is a form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency.

For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.

Kogenate is also used to associated treatment for these conditions: Bleeding, Hemophilia A, Perioperative Blood Loss, Bleeding in invasive procedures, Perioperative procedures

How Kogenate works

Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).

Food Interaction

No interactions found.

Half Life

8.4-19.3 hrs

Clearance

  • 4.1 mL/h•kg [Previously treated pediatric patients]

Innovators Monograph

You find simplified version here Kogenate

*** Taking medicines without doctor's advice can cause long-term problems.
Share